Our BDD interviewed by BioStock
Date: 2024-05-23
"We will be an obvious component in Big Pharma's Alzheimer's portfolio."
Read the full interview with Sebastian Hansson our Business Development Director. Link below.
"We will be an obvious component in Big Pharma's Alzheimer's portfolio."
Read the full interview with Sebastian Hansson our Business Development Director. Link below.